The Effects of Allicor on Patients After Revascularization Treatment During a Year
Status:
Not yet recruiting
Trial end date:
2024-05-31
Target enrollment:
Participant gender:
Summary
A valuable problem of medical care is atherosclerotic occlusion of peripheral arteries such
as lower extremities and brachycephalic arteries, which can eventually lead to loss of limbs
or fatal ischemic strokes. Revascularizing surgical interventions can restore the lumen of
the arteries and they are an effective way to treat such patients. However up to a third of
patients need re-intervention, or suffering cardiovascular complications within a year after
surgery. The purpose of our study is to evaluate the effect of the additional to the
conventional treatment intake the natural dietary supplement Allicor on the incidence of
cardiovascular complications and the effectiveness of treatment after 12 months after the
revascularization. Another valuable direction of investigations is the search for predictors
of long-term cardiovascular complications after revascularization, which can be markers of
inflammation and heteroplasmy levels of the patient's mitochondrial genome.